Company Filing History:
1 out of 4,179 
1 out of 167 
Years Active: 2014
Title: Dan Plata: Innovator in Serotonin Modulation
Introduction
Dan Plata, an inventive mind from Wadsworth, IL, has made significant contributions to the field of pharmacology with his unique approach to treating medical disorders. With a focus on serotonin 5HT6 receptors, his innovative inventions have the potential to impact therapeutic options for various conditions.
Latest Patents
Dan holds a patent for "Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor." This invention revolves around compounds defined by specific formulas, which are aimed at enhancing treatments for disorders sensitive to serotonin receptor modulation. The patent also discusses the application of these compounds or their pharmaceutically acceptable salts in preparing medications that target affected medical conditions.
Career Highlights
Throughout his career, Dan has worked with esteemed companies such as Abbott Laboratories Corporation and AbbVie Deutschland GmbH & Co. KG. His tenure at these organizations enabled him to deepen his expertise in pharmaceutical research and development.
Collaborations
Dan Plata has had the opportunity to collaborate with distinguished colleagues, including Roland Grandel and Wilfried Martin Braje. Their collective efforts have fostered a rich environment for innovation and the development of advanced therapeutic solutions.
Conclusion
As an inventor, Dan Plata continues to make strides in the pharmaceutical industry. His dedication to developing compounds that can effectively treat disorders related to the serotonin 5HT6 receptor reflects his passion for innovation and improving patient outcomes. His work showcases the critical role inventors play in enhancing medical treatment options.